Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron for Radiation-Induced Nausea and Vomiting
NCT00903396Phase 2Terminated
- Sponsor
- Cancer and Leukemia Group B
- Start
- Sep 2009
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palonosetron in radiation-induced nausea and vomiting (RINV), sponsored by Cancer and Leukemia Group B. Started Sep 2009; status: terminated.
02
Drugs
palonosetron
03
Conditions
radiation-induced nausea and vomiting (RINV)
Beyond the preview
Go deeper on NCT00903396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00903396.